P2-1: DM, Obesity

[P2-1-11] Duration of effect between new long-acting insulin glargine U300 and degludec in type 1 diabetes patients; a crossover clinical trial

^○Masakazu Hirose¹,Yuko Hotta¹, Kayako Hashimura¹, Yoneo Kashihara², Tomomi Hashimoto ², Takashi Higashide ², Shigeo Aono³, Tomoyuki Kawamura¹ (1.Department of Pediatrics, Osaka City University Graduate School of Medicine, 2.pediatrics, Hug Hug Kids Clinic, 3.Pediatrics, Teradacho Kodomo Clinic)